Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1778 of 5804
-
Stool test strategy aims to prevent UC Flare-Ups
Disease control Not yet recruitingDesign: Multicenter, Open-Label, Randomized, Parallel Controlled Allocation: 1:1 Randomization Masking: Open-label (outcome assessors blinded for endoscopy) Primary Purpose: Treatment Strategy Evaluation Phase: Phase IV (Post-Marketing Surveillance)
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New shockwave therapy could clear blocked heart arteries without major surgery
Disease control Not yet recruitingThis study aims to investigate the efficacy and safety of intravascular lithotripsy (IVL) balloon in treating coronary calcified lesions at our center.
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a simple Post-Surgery plan boost recovery for stomach cancer patients?
Symptom relief ENROLLING_BY_INVITATIONThis study was conducted by Qilu Hospital and five other renowned medical centers, aiming to evaluate the impact of early structured postoperative intervention on quality of life and prognosis in patients with gastric cancer after neoadjuvant therapy.
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Could a Steroid-Sparing cocktail tame chemo nausea?
Symptom relief Recruiting nowA phase II study evaluating dexamethasone sparing regimen with olanzapine and palonosetron for patients receiving high dose cisplatin to prevent chemotherapy induced nausea and vomiting
Phase: PHASE2 • Sponsor: Mahidol University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New device zaps remaining cancer cells during breast surgery
Disease control Recruiting nowThis study aims to assess the safety and clinical accuracy of the SIRA-1000, SIRA® RFA Electrosurgical Device in ablating margins post-lumpectomy in patients undergoing breast conserving surgery for breast cancer. Radiofrequency ablation, or RFA, uses radio waves to create heat, …
Phase: NA • Sponsor: Innoblative Designs, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New study tests whether eating by Cancer-Fighting guidelines can lower risk
Prevention Recruiting nowCancer is a leading cause of death and will affect many people in their lifetimes. Organizations such as the American Cancer Society and the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) have noted that dietary quality is a key factor influencing c…
Phase: NA • Sponsor: Drexel University • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Blood test may predict spinal injury recovery
Knowledge-focused Recruiting nowTo determine the accuracy of serum NF-L and GFAP levels (ie the biomarkers) at different time points postinjury for predicting the severity of neurologic impairment at 6 months postinjury as either motor complete (AIS grade A/B) or motor incomplete (AIS grade C/D) a group of pati…
Sponsor: AO Foundation, AO Spine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New dashboard aims to boost PrEP access and cut HIV disparities
Prevention Recruiting nowThe purpose of this study is to enhance and evaluate the implementation of a PrEP Care Continuum data dashboard across seven distinct clinical sites in Alabama. By leveraging real-time data and fostering collaborative partnerships, this project aims to accurately visualize care d…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
New eczema drug shows promise in Mid-Stage trial
Symptom relief Recruiting nowThe primary objective of this Phase 2 study is to evaluate the efficacy and safety of IBI3002 in patients with moderate to severe Atopic Dermatitis (AD).
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New diabetes drug CX11 shows promise in major trial
Disease control Recruiting nowThis study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good blood sugar control while taking a steady dose of metformin, with or without a steady dose of an SGLT2 inhibitor, for at least 90 days. Th…
Phase: PHASE2 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New shot could control blood pressure for months
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy, safety and tolerability of IBI3016 or placebo, given subcutaneously, every 3 or 6 months, at different dose levels in patients with mild to moderate hypertension
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Stroke recovery boost: nurse-led home rehab tested in bangladesh
Disease control Recruiting nowStroke causes various levels of disability which decreases physical function for a prolonged period. The purpose of this study is to evaluate the effectiveness of a nurse-led rehabilitation program including a multidisciplinary team focused on improving the functional ability amo…
Phase: NA • Sponsor: Hiroshima University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New pacemaker technique may cut AF risk in heart patients
Disease control Recruiting nowThis prospective, randomized controlled trial aims to evaluate the effect of left bundle branch pacing (LBBP) compared with conventional right ventricular (RV) pacing on the cumulative duration (total time) of atrial high-rate episodes (AHREs) in patients with preserved left vent…
Phase: NA • Sponsor: University Hospital of Patras • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Experimental drug aims to curb meth high in small trial
Disease control Recruiting nowThe purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disorder in the presence of a clini…
Phase: PHASE2 • Sponsor: Clear Scientific, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New study tests combo of CT scan and blood test for early lung cancer detection
Knowledge-focused Not yet recruitingThis study is a multi-center, observational study aiming to develop an early screening multi-model for detecting lung cancer signals through the integration of imaging (non-contrast CT) and blood testing (cfDNA methylation).
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Smart brain stimulator adjusts on the fly to help Parkinson's patients walk better
Disease control ENROLLING_BY_INVITATIONThis is a single-center clinical study aiming to improve gait functions in patients with Parkinson's Disease (PD) by using adaptive neurostimulation to the pallidum. The investigators will use a bidirectional deep brain stimulation device with sensing and stimulation capabilities…
Phase: NA • Sponsor: Doris Wang, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for rare brain diseases: long-term drug trial now recruiting
Disease control Recruiting nowThis open-label study aims to gather long-term safety, tolerability, PK, biomarker, and clinical efficacy data relating to daily administration of Nizubaglustat in participants previously enrolled in the Phase 2 RAINBOW study (Cohort 1). In addition, the study aims to assess safe…
Phase: PHASE2 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can zapping nerves ease back pain? new trial aims to find out
Symptom relief Recruiting nowThe purpose of the ASTRAL Study is to evaluate the effectiveness of LRFA (Lumbar radiofrequency ablation) against a control procedure. The ASTRAL Study will enroll individuals with chronic low back pain (CLBP) and randomly assign them to one of three groups: lumbar radiofrequency…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
From sofa to summit: study challenges sedentary adults to run 100 km race
Knowledge-focused Recruiting nowWe hypothesize, based on field and scientific data, that setting a very ambitious goal such as completing a mountain ultra-marathon could motivate sedentary and inactive individuals not only to begin training but also to follow a progressive yet extremely ambitious program that h…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
New pill could ease bipolar depression – trial underway
Symptom relief Recruiting nowBipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. This study will assess how safe and effective Icalcaprant is in treating adult participants with bipolar I or II disorder. …
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC